Skip to main content

EZH2 Test Your Knowledge

Test Your Knowledge
05/03/2021
Among patients with FL, approximately what percentage are reported as having activating mutations of EZH2?
Among patients with FL, approximately what percentage are reported as having activating mutations of EZH2?
Among patients with FL,...
05/03/2021
Oncology
Test Your Knowledge
03/15/2021
True or false: The FDA has approved tazemetostat for the treatment of patients with confirmed EZH2-positive relapsed/refractory FL.
True or false: The FDA has approved tazemetostat for the treatment of patients with confirmed EZH2-positive relapsed/refractory FL.
True or false: The FDA has...
03/15/2021
Oncology
Test Your Knowledge
02/03/2021
True or false: Tazemetostat has demonstrated durable activity in patients with relapsed/refractory FL and mutations in EZH2.
True or false: Tazemetostat has demonstrated durable activity in patients with relapsed/refractory FL and mutations in EZH2.
True or false: Tazemetostat has...
02/03/2021
Oncology
Test Your Knowledge
10/15/2020
True or False: EZH2 plays a critical role in promotion of tumor growth and metastasis, and can be regulated through multiple pathways transcriptionally, post-transcriptionally, and post-translationally.
True or False: EZH2 plays a critical role in promotion of tumor growth and metastasis, and can be regulated through multiple pathways transcriptionally, post-transcriptionally, and post-translationally.
True or False: EZH2 plays a...
10/15/2020
Oncology
Test Your Knowledge
08/13/2020
True or False: Tazemetostat is well-tolerated and yields anti-tumor activity in patients with BAP1-deficient relapsed or refractory malignant mesothelioma.
True or False: Tazemetostat is well-tolerated and yields anti-tumor activity in patients with BAP1-deficient relapsed or refractory malignant mesothelioma.
True or False: Tazemetostat is...
08/13/2020
Oncology
Test Your Knowledge
08/13/2020
In a large clinical study, which of the following agents yielded durable responses in patients with epithelioid sarcoma?
In a large clinical study, which of the following agents yielded durable responses in patients with epithelioid sarcoma?
In a large clinical study, which...
08/13/2020
Oncology